Login / Signup

Pharmacotherapy for Hospitalized Patients with COVID-19: Treatment Patterns by Disease Severity.

Kueiyu Joshua LinSebastian SchneeweissHelen TesfayeElvira D'AndreaJun LiuJoyce LiiShawn N MurphyJoshua J Gagne
Published in: Drugs (2020)
Careful consideration of disease severity and other determinants of COVID-19 drug use is necessary for appropriate conduct and interpretation of non-randomized studies evaluating outcomes of COVID-19 treatments.
Keyphrases
  • coronavirus disease
  • sars cov
  • double blind
  • open label
  • respiratory syndrome coronavirus
  • phase iii
  • clinical trial
  • smoking cessation
  • metabolic syndrome
  • combination therapy
  • weight loss
  • study protocol